Insider Ownership
CEOMORTIMER IAN
PRESIDENT & CEO
OtherKENNEY CHRISTOPHER JOHN
Chief Medical Officer
OtherDiFabio Andrea
Chief Legal Officer
OtherCline Darren S
Chief Commercial Officer
Transactions
50 transactions · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2022-08-12 | EMPFIELD JAMES R. | EVP, Drug Discovery | Sale+OE | 57,743 | $38.31 | $2,211,978.44 | -58.0% | → |
| 2022-08-12 | PIMSTONE SIMON N. | Director | Sell | 91,135 | $38.28 | $3,488,597.85 | -21.9% | → |
| 2022-03-08 | PIMSTONE SIMON N. | Director | Sale+OE | 54,962 | $29.28 | $1,609,320.57 | -1.8% | → |
| 2022-03-07 | EMPFIELD JAMES R. | EVP, Drug Discovery | Sale+OE | 51,168 | $30.63 | $1,567,393.87 | -45.6% | → |
| 2022-03-04 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sale+OE | 21,710 | $30.50 | $662,207.60 | -18.0% | → |
| 2022-01-21 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Buy | 700 | $28.81 | $20,167.00 | New | → |
| 2021-12-06 | Von Seggern Christopher | Chief Commercial Officer | Buy | 4,000 | $24.40 | $97,600.00 | New | → |
| 2021-11-15 | PIMSTONE SIMON N. | Director | Sell | 17,557 | $31.33 | $550,060.81 | -7.7% | → |
| 2021-05-28 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | Sale+OE | 6,067 | $18.81 | $114,120.27 | -8.3% | → |
| 2021-05-27 | HOLLER FRANK A | Director | Sale+OE | 11,064 | $18.68 | $206,701.31 | -3.6% | → |
| 2020-06-01 | PIMSTONE SIMON N. | CEO | Sell | 8,000 | $14.16 | $113,240.00 | -1.5% | → |
| 2019-09-20 | PIMSTONE SIMON N. | CEO | Sell | 10,395 | $9.51 | $98,856.45 | -3.9% | → |
| 2019-09-20 | HOLLER FRANK A | Director | Sell | 12,806 | $9.32 | $119,336.34 | -5.0% | → |
| 2019-09-18 | HOLLER FRANK A | Director | Sell | 9,437 | $9.30 | $87,778.12 | -3.4% | → |
| 2019-09-13 | AZAB MOHAMMAD | Director | Sell | 23 | $9.31 | $214.18 | - | → |
| 2017-11-15 | AZAB MOHAMMAD | - | Buy | 15,000 | $2.22 | $33,280.50 | +51.4% | → |
| 2017-09-22 | AZAB MOHAMMAD | - | Buy | 10,000 | $2.95 | $29,500.00 | +24.7% | → |
| 2017-08-18 | WINQUIST RAYMOND | Head, Translational Research | Buy | 1,000 | $3.00 | $2,995.00 | New | → |
| 2017-08-18 | AZAB MOHAMMAD | - | Buy | 6,335 | $2.90 | $18,362.59 | +24.6% | → |
| 2017-08-15 | EMPFIELD JAMES R. | SVP, Drug Discovery | Buy | 10,000 | $2.48 | $24,824.00 | New | → |
| 2017-08-15 | BVF PARTNERS L P/IL | - | Buy | 11,429 | $2.41 | $27,569.03 | +0.7% | → |